Skip navigation

Refine by Type

Results 1 - 10 of 11 for Vemurafenib
  1. Vemurafenib is used to treat certain types of melanoma (a type of skin cancer) that cannot be ... has spread to other parts of the body. Vemurafenib is in a class of medications called kinase ...
  2. Treatment Option Overview (Melanoma) From the National Institutes of Health (National Cancer Institute)  
    ... cell. Blocking these signals may kill cancer cells. Vemurafenib , dabrafenib , and trametinib are signal transduction inhibitors used ... or tumors that cannot be removed by surgery. Vemurafenib and dabrafenib block the activity of proteins made ...
  3. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... form (known as BRAF V600E) in many melanomas . Vemurafenib (Zelboraf®) targets this mutant form of the BRAF ... Sylvant™) , idelalisib (Zydelig®) , belinostat (Beleodaq™) Melanoma: Ipilimumab (Yervoy®) , vemurafenib (Zelboraf®) , trametinib (Mekinist®) , dabrafenib (Tafinlar®) , pembrolizumab (Keytruda®) , nivolumab ( ...
  4. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Velban (Vinblastine Sulfate) Velcade (Bortezomib) Velsar (Vinblastine Sulfate) Vemurafenib VePesid (Etoposide) Viadur (Leuprolide Acetate) Vidaza (Azacitidine) Vinblastine ...
  5. Drugs Approved for Skin Cancer From the National Institutes of Health (National Cancer Institute)  
    ... 2b Sylatron (Peginterferon Alfa-2b) Tafinlar (Dabrafenib) Trametinib Vemurafenib Yervoy (Ipilimumab) Zelboraf (Vemurafenib) Related Resources Skin Cancer ...
  6. ... in clinical trials. Some newer drugs, such as vemurafenib (Zelboraf ® ), dabrafenib (Tafinlar ® ), and trametinib (Mekinist TM ), target ...
  7. ... Drugs that target the BRAF protein, such as vemurafenib (Zelboraf) and dabrafenib (Tafinlar), as well as drugs ...
  8. Treatment Options by Stage (Melanoma) From the National Institutes of Health (National Cancer Institute)  
    ... melanoma may include the following: Targeted therapy with vemurafenib or dabrafenib . Biologic therapy with interleukin-2 (IL- ...
  9. ... target cells with BRAF gene changes, such as vemurafenib (Zelboraf ® ), dabrafenib, and selumetinib, are now being studied ...
  10. ... acid (Depakene); verapamil (Calan, Covera, Tarka, Verelan); and vemurafenib (Zelburaf). Many other medications may also interact with ...
previous · 1 · 2 · next